ArticleBlood cancer journal2017

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.

Y Kusano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.